Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Rang in Aktien #28495
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Aktienkurs
$1.09
Marktkapitalisierung
$26.57M
Veränderung (1 Tag)
-2.05%
Veränderung (1 Jahr)
54.68%
Land
KR
Handel Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategorie

EPS für Dong Sung Bio Pharm.Co.,Ltd. (002210)
EPS zum March 2026 TTM: $-0.70
Laut den aktuellen Finanzberichten und dem Aktienkurs von Dong Sung Bio Pharm.Co.,Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.70. Am Ende des Jahres 2023 betrug das EPS $-0.07 gleich wie dem EPS von 2022, das $-0.07 betrug.
EPS-Verlauf von Dong Sung Bio Pharm.Co.,Ltd. von 2007 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.70 217.00%
2024 $-0.22 208.27%
2023 $-0.07 -4.10%
2022 $-0.07 -52.90%
2021 $-0.16 -71.91%
2020 $-0.55 75.51%
2019 $-0.31 19.65%
2018 $-0.26 2,698.94%
2017 $-0.01 -86.40%
2016 $-0.07 -452.55%
2015 $0.02 -103.64%
2014 $-0.54 415.12%
2013 $-0.10 -161.47%
2012 $0.17 105.31%
2011 $0.08 -121.05%
2010 $-0.39 -1,573.03%
2009 $0.03 -82.85%
2008 $0.16 -4.48%
2007 $0.16 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber